Funder: American Cancer Society
Due Dates: October 29, 2024 (Electronic application deadline) | June 1, 2026 (Anticipated full application deadline)
Funding Amounts: Up to $215,000/year (Research Scholar Grant) or $430,000/year (Team Award), each for up to 4 years, plus 10% indirect costs; max total $946,000 (RSG) or $1,892,000 (Team).
Summary: Funds research to understand and prevent leukemia in individuals with RUNX1 familial platelet disorder, focusing on disease mechanisms and development of interception or prevention therapies.
Key Information: Applicants may submit only one proposal per cycle; only independent investigators at US nonprofits or academic institutions are eligible.